Literature DB >> 27457875

Patient knowledge concerning age-related macular degeneration: an AMD questionnaire.

Michael Burgmüller1,2, Nesrin Cakmak3, Birgit Weingessel4,3, Christina Vécsei4,3, Pia Veronika Vécsei-Marlovits4,3.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD) is a disease with rising prevalence. This study evaluates patients' knowledge and the need for more patient information.
METHODS: 271 patients with AMD were asked to complete a questionnaire concerning their knowledge about AMD. 150 patients were interviewed by a physician and 121 patients completed the questionnaire on their own.
RESULTS: 79.4 % of patients had previous knowledge about AMD. Most patients, 97.3 %, got their information from physicians. 58 % of patients find their knowledge concerning AMD adequate. Only 23.9 % knew about aid organizations for patients with visual impairments. DISCUSSION: Though the majority of patients had good knowledge concerning AMD, there was a large percentage of patients who seemed to lack information. Physicians should actively ask their patients if they have any questions related to their disease. Medial focus on AMD and information about aid organizations could help patients to cope with their disease.
CONCLUSION: A large number of patients seemed to need additional information. We suggest that ophthalmologists provide general information concerning AMD to their patients every 3 to 5 years. Information about aid organizations specializing in visual impairment could also be provided. Well-informed patients would be better able to follow their physician's instructions and would have a better understanding of their disease, particularly for the sake of therapy.

Entities:  

Keywords:  AMD; Age-related macular degeneration; Interview; Patient knowledge; Questionnaire

Mesh:

Year:  2016        PMID: 27457875     DOI: 10.1007/s00508-016-1044-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  18 in total

1.  Education, cognition, health knowledge, and health behavior.

Authors:  Naci Mocan; Duha T Altindag
Journal:  Eur J Health Econ       Date:  2013-04-02

2.  Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study.

Authors:  Christina A Korb; Ulrike B Kottler; Christian Wolfram; René Hoehn; Andreas Schulz; Isabella Zwiener; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

Review 3.  Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis.

Authors:  L Faes; N S Bodmer; L M Bachmann; M A Thiel; M K Schmid
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

4.  A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration.

Authors:  Ilse Krebs; Leopold Schmetterer; Agnes Boltz; Reinhard Told; Veronika Vécsei-Marlovits; Stefan Egger; Ulrich Schönherr; Anton Haas; Siamak Ansari-Shahrezaei; Susanne Binder
Journal:  Br J Ophthalmol       Date:  2013-01-03       Impact factor: 4.638

5.  Anxiety and depression prevalence rates in age-related macular degeneration.

Authors:  Albert Augustin; José-Alain Sahel; Francesco Bandello; Roland Dardennes; Frédérique Maurel; Cristina Negrini; Klaus Hieke; Gilles Berdeaux
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

6.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

Review 7.  Guidance for the treatment of neovascular age-related macular degeneration.

Authors:  Ursula M Schmidt-Erfurth; Gisbert Richard; Albert Augustin; William G Aylward; Francesco Bandello; Borja Corcòstegui; José Cunha-Vaz; Alain Gaudric; Anita Leys; Rainier O Schlingemann
Journal:  Acta Ophthalmol Scand       Date:  2007-08

Review 8.  The epidemiology of age-related macular degeneration.

Authors:  Ronald Klein; Tunde Peto; Alan Bird; Mylan R Vannewkirk
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

Review 9.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Authors:  Ursula Schmidt-Erfurth; Victor Chong; Anat Loewenstein; Michael Larsen; Eric Souied; Reinier Schlingemann; Bora Eldem; Jordi Monés; Gisbert Richard; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2014-09       Impact factor: 4.638

10.  Differences in simulated doctor and patient medical decision making: a construal level perspective.

Authors:  Jiaxi Peng; Fei He; Yan Zhang; Quanhui Liu; Danmin Miao; Wei Xiao
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.